Leading technology sales, marketing, and OEM channels for sensors. Developed strategy and executed plans for global integration across the ecosystem of dialysis machine platforms with miniaturized Crit-Line sensor technologies. Build and grow sales teams, delivering upon order and revenue measures, and develop strategies to grow expansion across multiple customer segments – Integrated Delivery Networks (IDNs), Payors, Healthcare Technology, and Manufacturers—intentional collaboration with other business teams in the design and framework of overarching healthcare strategy. Lead business development initiatives resulted in two new applications and devices delivering more than 77 million dollars in new sales revenue. I have initiated new selling concepts around omnichannel hybrid selling. Developed scalable digital ecosystems that drive innovations from the same sensor technology. Innovations Currently under development During my years with Fresenius, I was instrumental but certainly not alone in developing:ITAS- Integrated Therapy Anemia Systems. Creation of a digital twin avatar using physiological mathematical models of patients to create a more precise digital tool that personalizes the ESA dose for each patient. In a randomized controlled study, this technology improved ESA efficiency by 25% and the patient’s time in range by over 40% compared to the control arm. Adaptive UF- Received a 21st-century designation breakthrough status with the FDA for a class closed loop Ultrafiltration control dialysis machine that regulates the patient’s key biomarkers like percent change in blood volume to tailor the therapy more effectively in real-time to deliver better precision in the treatment. It is improving mortality and reducing hospitalizations. HEHO- I created a value-selling tool using health economics and health outcomes.Practical, hands-on experience with product launches. I have lobbied in Washington DC to Medicare & Medicaid Services (CMS) for Conditions of Coverage programs and payment for performance plans. Excellent record of managing operational costs and CAPEX budgeting. I have demonstrated a successful track record of leading projects that require cross-functional teams with R&D/ Regulatory/ Quality/ Marketing/ Manufacturing—initiated a line of complementary accessory products to complete a fluid management eco-system for patient care. Products included segmental bio-impedance and resistivity monitoring for extracellular and intracellular fluid intelligence.